Related Experiment Video
Updated: Jun 16, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Atrial fibrillation: clinical end-points, morbidity and mortality, life expectancy]
1Centre cardiologique du Nord, rue des Moulins Gémeaux, Saint-Denis, France. x.copie@ccncardio.com
Annales De Cardiologie Et D'Angeiologie
|January 28, 2010
Insights
Atrial fibrillation (AF) shortens life expectancy in patients with cardiovascular disease. However, lone AF does not increase mortality unless comorbidities develop.
Area of Science:
- Cardiology
- Epidemiology
- Clinical Medicine
Context:
- Atrial fibrillation (AF) is a common arrhythmia impacting patient prognosis.
- Cardiovascular disease (CVD) is a major determinant of mortality.
- The prognostic implications of lone AF, particularly concerning life expectancy, require further elucidation.
Purpose:
- To investigate the impact of lone atrial fibrillation on life expectancy.
- To determine if lone AF, in the absence of other conditions, affects mortality.
- To assess how comorbidities influence the life expectancy of patients with lone AF.
Summary:
- Atrial fibrillation (AF) is linked to reduced life expectancy in individuals with cardiovascular disease.
- Lone atrial fibrillation, defined as AF without other underlying heart conditions, is not associated with increased mortality.
- However, the development of comorbidities over time in patients with lone AF can lead to a decrease in life expectancy.
Impact:
- This research clarifies the prognostic significance of lone AF, differentiating it from AF in the context of established cardiovascular disease.
- Findings emphasize the critical role of comorbidities in modulating the long-term outcomes of patients with lone AF.
- Provides essential information for clinical risk stratification and management strategies for patients diagnosed with lone atrial fibrillation.
Abstract:
Atrial fibrillation (AF) shortens life expectancy in patients with cardiovascular disease. Lone atrial fibrillation is not associated with an excess in mortality. However, lone atrial fibrillation decreases life expectancy when associated with comorbidities during its evolution.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...